nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—Electrocardiogram ST segment depression—Varenicline—nicotine dependence	0.0207	0.0382	CcSEcCtD
Doxorubicin—RALBP1—Regulation of CDC42 activity—FGD1—nicotine dependence	0.0186	0.108	CbGpPWpGaD
Doxorubicin—AKR1A1—cardiovascular system—nicotine dependence	0.0132	0.0463	CbGeAlD
Doxorubicin—POR—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0128	0.0746	CbGpPWpGaD
Doxorubicin—Musculoskeletal chest pain—Varenicline—nicotine dependence	0.0121	0.0223	CcSEcCtD
Doxorubicin—NDUFS7—cardiovascular system—nicotine dependence	0.012	0.0421	CbGeAlD
Doxorubicin—Drug hypersensitivity—Varenicline—nicotine dependence	0.0117	0.0215	CcSEcCtD
Doxorubicin—Haematochezia—Varenicline—nicotine dependence	0.0117	0.0215	CcSEcCtD
Doxorubicin—AKR1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0108	0.063	CbGpPWpGaD
Doxorubicin—AKR1A1—midbrain—nicotine dependence	0.0103	0.0361	CbGeAlD
Doxorubicin—AKR1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.01	0.0586	CbGpPWpGaD
Doxorubicin—Aphthous stomatitis—Varenicline—nicotine dependence	0.01	0.0185	CcSEcCtD
Doxorubicin—NOS1—cardiovascular system—nicotine dependence	0.01	0.0351	CbGeAlD
Doxorubicin—NDUFS2—cardiovascular system—nicotine dependence	0.00994	0.0349	CbGeAlD
Doxorubicin—NDUFS3—cardiovascular system—nicotine dependence	0.00982	0.0344	CbGeAlD
Doxorubicin—Peripheral vascular disorder—Varenicline—nicotine dependence	0.0096	0.0177	CcSEcCtD
Doxorubicin—Myositis—Varenicline—nicotine dependence	0.0096	0.0177	CcSEcCtD
Doxorubicin—NDUFS7—midbrain—nicotine dependence	0.00937	0.0329	CbGeAlD
Doxorubicin—ABCC6—cardiovascular system—nicotine dependence	0.00909	0.0319	CbGeAlD
Doxorubicin—ABCB8—brain—nicotine dependence	0.00871	0.0306	CbGeAlD
Doxorubicin—YWHAG—cardiovascular system—nicotine dependence	0.00856	0.03	CbGeAlD
Doxorubicin—Urine abnormality—Varenicline—nicotine dependence	0.0085	0.0156	CcSEcCtD
Doxorubicin—CBR3—brain—nicotine dependence	0.00839	0.0294	CbGeAlD
Doxorubicin—Gastric ulcer—Varenicline—nicotine dependence	0.0081	0.0149	CcSEcCtD
Doxorubicin—Urine analysis abnormal—Varenicline—nicotine dependence	0.00801	0.0147	CcSEcCtD
Doxorubicin—NDUFS2—midbrain—nicotine dependence	0.00776	0.0272	CbGeAlD
Doxorubicin—Vaginal discharge—Varenicline—nicotine dependence	0.00774	0.0142	CcSEcCtD
Doxorubicin—RALBP1—cardiovascular system—nicotine dependence	0.00773	0.0271	CbGeAlD
Doxorubicin—NDUFS3—midbrain—nicotine dependence	0.00767	0.0269	CbGeAlD
Doxorubicin—NOS3—cardiovascular system—nicotine dependence	0.0076	0.0267	CbGeAlD
Doxorubicin—Psoriasis—Varenicline—nicotine dependence	0.00749	0.0138	CcSEcCtD
Doxorubicin—DHCR7—midbrain—nicotine dependence	0.00728	0.0256	CbGeAlD
Doxorubicin—Parosmia—Varenicline—nicotine dependence	0.00726	0.0134	CcSEcCtD
Doxorubicin—CBR1—cardiovascular system—nicotine dependence	0.00722	0.0253	CbGeAlD
Doxorubicin—AKR1C3—Retinoid metabolism and transport—AKR1B10—nicotine dependence	0.00707	0.0413	CbGpPWpGaD
Doxorubicin—Cyst—Varenicline—nicotine dependence	0.00704	0.013	CcSEcCtD
Doxorubicin—Haematemesis—Varenicline—nicotine dependence	0.00678	0.0125	CcSEcCtD
Doxorubicin—YWHAG—midbrain—nicotine dependence	0.00668	0.0234	CbGeAlD
Doxorubicin—Thrombosis—Varenicline—nicotine dependence	0.00665	0.0122	CcSEcCtD
Doxorubicin—Nystagmus—Varenicline—nicotine dependence	0.00659	0.0121	CcSEcCtD
Doxorubicin—Hyperlipidaemia—Varenicline—nicotine dependence	0.00653	0.012	CcSEcCtD
Doxorubicin—AKR1A1—brain—nicotine dependence	0.00648	0.0227	CbGeAlD
Doxorubicin—CYP2B6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00626	0.0365	CbGpPWpGaD
Doxorubicin—RALBP1—Rho GTPase cycle—FGD1—nicotine dependence	0.0062	0.0362	CbGpPWpGaD
Doxorubicin—Scotoma—Varenicline—nicotine dependence	0.0062	0.0114	CcSEcCtD
Doxorubicin—Fungal infection—Varenicline—nicotine dependence	0.0061	0.0112	CcSEcCtD
Doxorubicin—RALBP1—midbrain—nicotine dependence	0.00604	0.0212	CbGeAlD
Doxorubicin—Gingivitis—Varenicline—nicotine dependence	0.006	0.011	CcSEcCtD
Doxorubicin—NDUFS7—brain—nicotine dependence	0.00589	0.0206	CbGeAlD
Doxorubicin—Glycosuria—Varenicline—nicotine dependence	0.00581	0.0107	CcSEcCtD
Doxorubicin—NQO1—cardiovascular system—nicotine dependence	0.00578	0.0203	CbGeAlD
Doxorubicin—Dysphonia—Varenicline—nicotine dependence	0.00572	0.0105	CcSEcCtD
Doxorubicin—CBR1—midbrain—nicotine dependence	0.00563	0.0198	CbGeAlD
Doxorubicin—AKR1C3—midbrain—nicotine dependence	0.00557	0.0195	CbGeAlD
Doxorubicin—AURKA—brain—nicotine dependence	0.00547	0.0192	CbGeAlD
Doxorubicin—Ventricular extrasystoles—Varenicline—nicotine dependence	0.00521	0.00959	CcSEcCtD
Doxorubicin—Viral infection—Varenicline—nicotine dependence	0.00521	0.00959	CcSEcCtD
Doxorubicin—Thinking abnormal—Varenicline—nicotine dependence	0.00514	0.00946	CcSEcCtD
Doxorubicin—Lacrimation increased—Varenicline—nicotine dependence	0.00511	0.0094	CcSEcCtD
Doxorubicin—POR—midbrain—nicotine dependence	0.00508	0.0178	CbGeAlD
Doxorubicin—Nocturia—Varenicline—nicotine dependence	0.00508	0.00934	CcSEcCtD
Doxorubicin—Dysarthria—Varenicline—nicotine dependence	0.00498	0.00916	CcSEcCtD
Doxorubicin—NOS1—brain—nicotine dependence	0.00491	0.0172	CbGeAlD
Doxorubicin—CYP2B6—Fatty acids—CYP2A7—nicotine dependence	0.00488	0.0285	CbGpPWpGaD
Doxorubicin—NDUFS2—brain—nicotine dependence	0.00488	0.0171	CbGeAlD
Doxorubicin—NDUFS3—brain—nicotine dependence	0.00482	0.0169	CbGeAlD
Doxorubicin—Coordination abnormal—Varenicline—nicotine dependence	0.00479	0.00882	CcSEcCtD
Doxorubicin—Musculoskeletal pain—Varenicline—nicotine dependence	0.00477	0.00877	CcSEcCtD
Doxorubicin—Pulmonary embolism—Varenicline—nicotine dependence	0.00471	0.00866	CcSEcCtD
Doxorubicin—Abnormal dreams—Varenicline—nicotine dependence	0.00465	0.00856	CcSEcCtD
Doxorubicin—Hyperkalaemia—Varenicline—nicotine dependence	0.00463	0.00851	CcSEcCtD
Doxorubicin—Eructation—Varenicline—nicotine dependence	0.00463	0.00851	CcSEcCtD
Doxorubicin—DHCR7—brain—nicotine dependence	0.00458	0.0161	CbGeAlD
Doxorubicin—Salivary hypersecretion—Varenicline—nicotine dependence	0.00457	0.00841	CcSEcCtD
Doxorubicin—Influenza like illness—Varenicline—nicotine dependence	0.00457	0.00841	CcSEcCtD
Doxorubicin—NQO1—midbrain—nicotine dependence	0.00451	0.0158	CbGeAlD
Doxorubicin—Dry eye—Varenicline—nicotine dependence	0.00435	0.008	CcSEcCtD
Doxorubicin—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00435	0.0254	CbGpPWpGaD
Doxorubicin—Oesophagitis—Varenicline—nicotine dependence	0.0043	0.00791	CcSEcCtD
Doxorubicin—Mouth ulceration—Varenicline—nicotine dependence	0.00426	0.00783	CcSEcCtD
Doxorubicin—YWHAG—brain—nicotine dependence	0.0042	0.0147	CbGeAlD
Doxorubicin—Hypertonia—Varenicline—nicotine dependence	0.00413	0.00759	CcSEcCtD
Doxorubicin—Mental disability—Varenicline—nicotine dependence	0.00409	0.00752	CcSEcCtD
Doxorubicin—CYP1B1—cardiovascular system—nicotine dependence	0.00406	0.0142	CbGeAlD
Doxorubicin—ABCC10—midbrain—nicotine dependence	0.00403	0.0141	CbGeAlD
Doxorubicin—Lymphadenopathy—Varenicline—nicotine dependence	0.00401	0.00737	CcSEcCtD
Doxorubicin—Diabetes mellitus—Varenicline—nicotine dependence	0.00393	0.00723	CcSEcCtD
Doxorubicin—CYP2B6—Xenobiotics—CYP2A7—nicotine dependence	0.00388	0.0226	CbGpPWpGaD
Doxorubicin—Eczema—Varenicline—nicotine dependence	0.0038	0.007	CcSEcCtD
Doxorubicin—RALBP1—brain—nicotine dependence	0.00379	0.0133	CbGeAlD
Doxorubicin—Eye pain—Varenicline—nicotine dependence	0.00379	0.00696	CcSEcCtD
Doxorubicin—NOS3—brain—nicotine dependence	0.00373	0.0131	CbGeAlD
Doxorubicin—Renal failure acute—Varenicline—nicotine dependence	0.0037	0.00681	CcSEcCtD
Doxorubicin—Hot flush—Varenicline—nicotine dependence	0.00365	0.00672	CcSEcCtD
Doxorubicin—Increased appetite—Varenicline—nicotine dependence	0.00364	0.00669	CcSEcCtD
Doxorubicin—Menopausal symptoms—Varenicline—nicotine dependence	0.00362	0.00666	CcSEcCtD
Doxorubicin—AKR1C3—Diseases associated with visual transduction—AKR1B10—nicotine dependence	0.00361	0.0211	CbGpPWpGaD
Doxorubicin—CBR1—brain—nicotine dependence	0.00354	0.0124	CbGeAlD
Doxorubicin—Hypoglycaemia—Varenicline—nicotine dependence	0.0035	0.00644	CcSEcCtD
Doxorubicin—AKR1C3—brain—nicotine dependence	0.0035	0.0123	CbGeAlD
Doxorubicin—Lethargy—Varenicline—nicotine dependence	0.00349	0.00642	CcSEcCtD
Doxorubicin—Cerebrovascular accident—Varenicline—nicotine dependence	0.00349	0.00642	CcSEcCtD
Doxorubicin—Osteoarthritis—Varenicline—nicotine dependence	0.00342	0.00629	CcSEcCtD
Doxorubicin—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.00342	0.00629	CcSEcCtD
Doxorubicin—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00339	0.0198	CbGpPWpGaD
Doxorubicin—Migraine—Varenicline—nicotine dependence	0.00336	0.00619	CcSEcCtD
Doxorubicin—Affect lability—Varenicline—nicotine dependence	0.00336	0.00619	CcSEcCtD
Doxorubicin—Mood swings—Varenicline—nicotine dependence	0.00324	0.00596	CcSEcCtD
Doxorubicin—POR—brain—nicotine dependence	0.00319	0.0112	CbGeAlD
Doxorubicin—ABCB8—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00316	0.0185	CbGpPWpGaD
Doxorubicin—Liver function test abnormal—Varenicline—nicotine dependence	0.00316	0.0058	CcSEcCtD
Doxorubicin—Dry skin—Varenicline—nicotine dependence	0.00313	0.00576	CcSEcCtD
Doxorubicin—Abdominal pain upper—Varenicline—nicotine dependence	0.00312	0.00574	CcSEcCtD
Doxorubicin—Hypokalaemia—Varenicline—nicotine dependence	0.00311	0.00572	CcSEcCtD
Doxorubicin—Breast disorder—Varenicline—nicotine dependence	0.00309	0.00568	CcSEcCtD
Doxorubicin—Nasopharyngitis—Varenicline—nicotine dependence	0.00306	0.00562	CcSEcCtD
Doxorubicin—Gastritis—Varenicline—nicotine dependence	0.00302	0.00556	CcSEcCtD
Doxorubicin—Abdominal distension—Varenicline—nicotine dependence	0.00297	0.00547	CcSEcCtD
Doxorubicin—Asthma—Varenicline—nicotine dependence	0.00295	0.00543	CcSEcCtD
Doxorubicin—Dysphagia—Varenicline—nicotine dependence	0.00295	0.00543	CcSEcCtD
Doxorubicin—Angina pectoris—Varenicline—nicotine dependence	0.00288	0.00529	CcSEcCtD
Doxorubicin—Bronchitis—Varenicline—nicotine dependence	0.00284	0.00523	CcSEcCtD
Doxorubicin—NQO1—brain—nicotine dependence	0.00284	0.00995	CbGeAlD
Doxorubicin—CYP2B6—cardiovascular system—nicotine dependence	0.00279	0.00978	CbGeAlD
Doxorubicin—Pollakiuria—Varenicline—nicotine dependence	0.00273	0.00502	CcSEcCtD
Doxorubicin—Photosensitivity reaction—Varenicline—nicotine dependence	0.0027	0.00496	CcSEcCtD
Doxorubicin—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.0027	0.0157	CbGpPWpGaD
Doxorubicin—Weight increased—Varenicline—nicotine dependence	0.00269	0.00495	CcSEcCtD
Doxorubicin—Hyperglycaemia—Varenicline—nicotine dependence	0.00266	0.0049	CcSEcCtD
Doxorubicin—Infestation—Varenicline—nicotine dependence	0.00263	0.00485	CcSEcCtD
Doxorubicin—Infestation NOS—Varenicline—nicotine dependence	0.00263	0.00485	CcSEcCtD
Doxorubicin—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00261	0.0048	CcSEcCtD
Doxorubicin—Stomatitis—Varenicline—nicotine dependence	0.00257	0.00472	CcSEcCtD
Doxorubicin—Conjunctivitis—Varenicline—nicotine dependence	0.00256	0.00471	CcSEcCtD
Doxorubicin—ABCC3—brain—nicotine dependence	0.00255	0.00893	CbGeAlD
Doxorubicin—ABCC10—brain—nicotine dependence	0.00253	0.00889	CbGeAlD
Doxorubicin—YWHAG—ErbB1 downstream signaling—WASF2—nicotine dependence	0.0025	0.0146	CbGpPWpGaD
Doxorubicin—Hepatobiliary disease—Varenicline—nicotine dependence	0.00249	0.00458	CcSEcCtD
Doxorubicin—Epistaxis—Varenicline—nicotine dependence	0.00248	0.00457	CcSEcCtD
Doxorubicin—Sinusitis—Varenicline—nicotine dependence	0.00247	0.00455	CcSEcCtD
Doxorubicin—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00241	0.0141	CbGpPWpGaD
Doxorubicin—Bradycardia—Varenicline—nicotine dependence	0.00241	0.00443	CcSEcCtD
Doxorubicin—CYP1B1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00238	0.0139	CbGpPWpGaD
Doxorubicin—ABCG2—midbrain—nicotine dependence	0.00236	0.00828	CbGeAlD
Doxorubicin—Hypoaesthesia—Varenicline—nicotine dependence	0.00235	0.00433	CcSEcCtD
Doxorubicin—Urinary tract disorder—Varenicline—nicotine dependence	0.00233	0.0043	CcSEcCtD
Doxorubicin—Oedema peripheral—Varenicline—nicotine dependence	0.00233	0.00428	CcSEcCtD
Doxorubicin—Connective tissue disorder—Varenicline—nicotine dependence	0.00232	0.00427	CcSEcCtD
Doxorubicin—Urethral disorder—Varenicline—nicotine dependence	0.00232	0.00426	CcSEcCtD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.0023	0.0134	CbGpPWpGaD
Doxorubicin—Visual impairment—Varenicline—nicotine dependence	0.00228	0.00419	CcSEcCtD
Doxorubicin—Erythema multiforme—Varenicline—nicotine dependence	0.00224	0.00411	CcSEcCtD
Doxorubicin—AKR1C3—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00222	0.0129	CbGpPWpGaD
Doxorubicin—Eye disorder—Varenicline—nicotine dependence	0.00221	0.00406	CcSEcCtD
Doxorubicin—Tinnitus—Varenicline—nicotine dependence	0.0022	0.00406	CcSEcCtD
Doxorubicin—Cardiac disorder—Varenicline—nicotine dependence	0.00219	0.00404	CcSEcCtD
Doxorubicin—YWHAG—PDGFR-beta signaling pathway—WASF2—nicotine dependence	0.00217	0.0127	CbGpPWpGaD
Doxorubicin—Angiopathy—Varenicline—nicotine dependence	0.00215	0.00395	CcSEcCtD
Doxorubicin—Immune system disorder—Varenicline—nicotine dependence	0.00214	0.00393	CcSEcCtD
Doxorubicin—Mediastinal disorder—Varenicline—nicotine dependence	0.00213	0.00392	CcSEcCtD
Doxorubicin—Chills—Varenicline—nicotine dependence	0.00212	0.0039	CcSEcCtD
Doxorubicin—Arrhythmia—Varenicline—nicotine dependence	0.00211	0.00389	CcSEcCtD
Doxorubicin—Mental disorder—Varenicline—nicotine dependence	0.00207	0.00381	CcSEcCtD
Doxorubicin—AKR1C3—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00206	0.012	CbGpPWpGaD
Doxorubicin—Erythema—Varenicline—nicotine dependence	0.00206	0.00379	CcSEcCtD
Doxorubicin—Malnutrition—Varenicline—nicotine dependence	0.00206	0.00379	CcSEcCtD
Doxorubicin—Flatulence—Varenicline—nicotine dependence	0.00203	0.00373	CcSEcCtD
Doxorubicin—Dysgeusia—Varenicline—nicotine dependence	0.00202	0.00371	CcSEcCtD
Doxorubicin—CYP1B1—brain—nicotine dependence	0.00199	0.00699	CbGeAlD
Doxorubicin—Back pain—Varenicline—nicotine dependence	0.00199	0.00366	CcSEcCtD
Doxorubicin—Muscle spasms—Varenicline—nicotine dependence	0.00198	0.00364	CcSEcCtD
Doxorubicin—CYP1B1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00196	0.0114	CbGpPWpGaD
Doxorubicin—NOS3—VEGFA-VEGFR2 Pathway—WASF2—nicotine dependence	0.00195	0.0114	CbGpPWpGaD
Doxorubicin—SLC22A16—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00195	0.0114	CbGpPWpGaD
Doxorubicin—Vision blurred—Varenicline—nicotine dependence	0.00194	0.00357	CcSEcCtD
Doxorubicin—Ill-defined disorder—Varenicline—nicotine dependence	0.00191	0.00351	CcSEcCtD
Doxorubicin—Anaemia—Varenicline—nicotine dependence	0.0019	0.0035	CcSEcCtD
Doxorubicin—Agitation—Varenicline—nicotine dependence	0.00189	0.00348	CcSEcCtD
Doxorubicin—NOS3—VEGFA-VEGFR2 Pathway—WASF1—nicotine dependence	0.00187	0.0109	CbGpPWpGaD
Doxorubicin—Malaise—Varenicline—nicotine dependence	0.00186	0.00341	CcSEcCtD
Doxorubicin—Vertigo—Varenicline—nicotine dependence	0.00185	0.0034	CcSEcCtD
Doxorubicin—Syncope—Varenicline—nicotine dependence	0.00185	0.0034	CcSEcCtD
Doxorubicin—NOS3—Signaling by VEGF—WASF2—nicotine dependence	0.00185	0.0108	CbGpPWpGaD
Doxorubicin—Palpitations—Varenicline—nicotine dependence	0.00182	0.00335	CcSEcCtD
Doxorubicin—Loss of consciousness—Varenicline—nicotine dependence	0.00181	0.00333	CcSEcCtD
Doxorubicin—Cough—Varenicline—nicotine dependence	0.0018	0.0033	CcSEcCtD
Doxorubicin—ABCC1—brain—nicotine dependence	0.00179	0.00629	CbGeAlD
Doxorubicin—Convulsion—Varenicline—nicotine dependence	0.00178	0.00328	CcSEcCtD
Doxorubicin—Hypertension—Varenicline—nicotine dependence	0.00178	0.00327	CcSEcCtD
Doxorubicin—NOS3—Signaling by VEGF—WASF1—nicotine dependence	0.00177	0.0103	CbGpPWpGaD
Doxorubicin—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00176	0.0103	CbGpPWpGaD
Doxorubicin—Arthralgia—Varenicline—nicotine dependence	0.00175	0.00322	CcSEcCtD
Doxorubicin—Chest pain—Varenicline—nicotine dependence	0.00175	0.00322	CcSEcCtD
Doxorubicin—Myalgia—Varenicline—nicotine dependence	0.00175	0.00322	CcSEcCtD
Doxorubicin—Anxiety—Varenicline—nicotine dependence	0.00175	0.00321	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00174	0.0032	CcSEcCtD
Doxorubicin—Discomfort—Varenicline—nicotine dependence	0.00173	0.00318	CcSEcCtD
Doxorubicin—Dry mouth—Varenicline—nicotine dependence	0.00171	0.00315	CcSEcCtD
Doxorubicin—Oedema—Varenicline—nicotine dependence	0.00168	0.00309	CcSEcCtD
Doxorubicin—Infection—Varenicline—nicotine dependence	0.00167	0.00307	CcSEcCtD
Doxorubicin—Shock—Varenicline—nicotine dependence	0.00165	0.00304	CcSEcCtD
Doxorubicin—Nervous system disorder—Varenicline—nicotine dependence	0.00165	0.00303	CcSEcCtD
Doxorubicin—Thrombocytopenia—Varenicline—nicotine dependence	0.00164	0.00303	CcSEcCtD
Doxorubicin—Tachycardia—Varenicline—nicotine dependence	0.00164	0.00302	CcSEcCtD
Doxorubicin—Skin disorder—Varenicline—nicotine dependence	0.00163	0.003	CcSEcCtD
Doxorubicin—Hyperhidrosis—Varenicline—nicotine dependence	0.00162	0.00299	CcSEcCtD
Doxorubicin—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00161	0.0094	CbGpPWpGaD
Doxorubicin—Anorexia—Varenicline—nicotine dependence	0.0016	0.00295	CcSEcCtD
Doxorubicin—CYP2B6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00159	0.00928	CbGpPWpGaD
Doxorubicin—Hypotension—Varenicline—nicotine dependence	0.00157	0.00289	CcSEcCtD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00154	0.00897	CbGpPWpGaD
Doxorubicin—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00153	0.00282	CcSEcCtD
Doxorubicin—Insomnia—Varenicline—nicotine dependence	0.00152	0.00279	CcSEcCtD
Doxorubicin—Dyspnoea—Varenicline—nicotine dependence	0.0015	0.00275	CcSEcCtD
Doxorubicin—Somnolence—Varenicline—nicotine dependence	0.00149	0.00275	CcSEcCtD
Doxorubicin—ABCB1—cardiovascular system—nicotine dependence	0.00149	0.00523	CbGeAlD
Doxorubicin—ABCG2—brain—nicotine dependence	0.00148	0.0052	CbGeAlD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00148	0.00864	CbGpPWpGaD
Doxorubicin—Dyspepsia—Varenicline—nicotine dependence	0.00148	0.00272	CcSEcCtD
Doxorubicin—Decreased appetite—Varenicline—nicotine dependence	0.00146	0.00269	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00145	0.00267	CcSEcCtD
Doxorubicin—Fatigue—Varenicline—nicotine dependence	0.00145	0.00266	CcSEcCtD
Doxorubicin—Constipation—Varenicline—nicotine dependence	0.00144	0.00264	CcSEcCtD
Doxorubicin—Pain—Varenicline—nicotine dependence	0.00144	0.00264	CcSEcCtD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00139	0.00814	CbGpPWpGaD
Doxorubicin—Feeling abnormal—Varenicline—nicotine dependence	0.00138	0.00255	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Varenicline—nicotine dependence	0.00137	0.00253	CcSEcCtD
Doxorubicin—CYP2B6—brain—nicotine dependence	0.00137	0.0048	CbGeAlD
Doxorubicin—Urticaria—Varenicline—nicotine dependence	0.00133	0.00245	CcSEcCtD
Doxorubicin—Abdominal pain—Varenicline—nicotine dependence	0.00133	0.00244	CcSEcCtD
Doxorubicin—Body temperature increased—Varenicline—nicotine dependence	0.00133	0.00244	CcSEcCtD
Doxorubicin—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00131	0.00762	CbGpPWpGaD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00129	0.00755	CbGpPWpGaD
Doxorubicin—NOS2—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00128	0.00749	CbGpPWpGaD
Doxorubicin—Hypersensitivity—Varenicline—nicotine dependence	0.00124	0.00228	CcSEcCtD
Doxorubicin—Asthenia—Varenicline—nicotine dependence	0.00121	0.00222	CcSEcCtD
Doxorubicin—Pruritus—Varenicline—nicotine dependence	0.00119	0.00219	CcSEcCtD
Doxorubicin—ABCB1—midbrain—nicotine dependence	0.00116	0.00408	CbGeAlD
Doxorubicin—Diarrhoea—Varenicline—nicotine dependence	0.00115	0.00211	CcSEcCtD
Doxorubicin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00112	0.00653	CbGpPWpGaD
Doxorubicin—Dizziness—Varenicline—nicotine dependence	0.00111	0.00204	CcSEcCtD
Doxorubicin—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0011	0.00645	CbGpPWpGaD
Doxorubicin—CYP1B1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0011	0.00644	CbGpPWpGaD
Doxorubicin—Vomiting—Varenicline—nicotine dependence	0.00107	0.00196	CcSEcCtD
Doxorubicin—Rash—Varenicline—nicotine dependence	0.00106	0.00195	CcSEcCtD
Doxorubicin—Dermatitis—Varenicline—nicotine dependence	0.00106	0.00195	CcSEcCtD
Doxorubicin—Headache—Varenicline—nicotine dependence	0.00105	0.00194	CcSEcCtD
Doxorubicin—CYP1B1—Biological oxidations—CYP2A7—nicotine dependence	0.00104	0.00607	CbGpPWpGaD
Doxorubicin—CYP1B1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00103	0.00599	CbGpPWpGaD
Doxorubicin—CYP2D6—brain—nicotine dependence	0.00102	0.00357	CbGeAlD
Doxorubicin—Nausea—Varenicline—nicotine dependence	0.000998	0.00184	CcSEcCtD
Doxorubicin—NOS2—Circadian rythm related genes—DRD2—nicotine dependence	0.000949	0.00554	CbGpPWpGaD
Doxorubicin—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000907	0.0053	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000877	0.00512	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—CYP2A7—nicotine dependence	0.00085	0.00496	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—CYP2A7—nicotine dependence	0.00085	0.00496	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TAS2R16—nicotine dependence	0.000836	0.00488	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—CYP2A7—nicotine dependence	0.000799	0.00467	CbGpPWpGaD
Doxorubicin—CYP2B6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000736	0.00429	CbGpPWpGaD
Doxorubicin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000732	0.00427	CbGpPWpGaD
Doxorubicin—ABCB1—brain—nicotine dependence	0.000732	0.00257	CbGeAlD
Doxorubicin—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000722	0.00422	CbGpPWpGaD
Doxorubicin—CYP2B6—Biological oxidations—CYP2A7—nicotine dependence	0.000693	0.00405	CbGpPWpGaD
Doxorubicin—CYP2B6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000684	0.00399	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—CYP2A7—nicotine dependence	0.00068	0.00397	CbGpPWpGaD
Doxorubicin—NOS1—Disease—AKR1B10—nicotine dependence	0.000662	0.00386	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—FGD1—nicotine dependence	0.000656	0.00383	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—DRD2—nicotine dependence	0.000649	0.00379	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—CYP2A7—nicotine dependence	0.000634	0.0037	CbGpPWpGaD
Doxorubicin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000593	0.00346	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—AKR1B10—nicotine dependence	0.00058	0.00338	CbGpPWpGaD
Doxorubicin—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000511	0.00298	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000501	0.00292	CbGpPWpGaD
Doxorubicin—NOS2—Disease—AKR1B10—nicotine dependence	0.000499	0.00291	CbGpPWpGaD
Doxorubicin—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000482	0.00281	CbGpPWpGaD
Doxorubicin—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000475	0.00277	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TAS2R16—nicotine dependence	0.000463	0.0027	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—AKR1B10—nicotine dependence	0.000459	0.00268	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—WASF2—nicotine dependence	0.000408	0.00238	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000397	0.00232	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000393	0.00229	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—WASF1—nicotine dependence	0.000391	0.00229	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TAS2R16—nicotine dependence	0.000391	0.00229	CbGpPWpGaD
Doxorubicin—NOS3—Disease—AKR1B10—nicotine dependence	0.000388	0.00226	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—CYP2A7—nicotine dependence	0.00037	0.00216	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—FGD1—nicotine dependence	0.000364	0.00212	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—CYP2A7—nicotine dependence	0.000357	0.00208	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—OPRM1—nicotine dependence	0.000352	0.00206	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000345	0.00202	CbGpPWpGaD
Doxorubicin—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000334	0.00195	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—CYP2A7—nicotine dependence	0.000332	0.00194	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—AKR1B10—nicotine dependence	0.000321	0.00187	CbGpPWpGaD
Doxorubicin—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000315	0.00184	CbGpPWpGaD
Doxorubicin—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000311	0.00181	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—FGD1—nicotine dependence	0.000307	0.00179	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—CYP2A7—nicotine dependence	0.000302	0.00176	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—AKR1B10—nicotine dependence	0.000271	0.00158	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—DRD2—nicotine dependence	0.000255	0.00149	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—CYP2A7—nicotine dependence	0.000245	0.00143	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—AKR1B10—nicotine dependence	0.000236	0.00138	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CYP2A7—nicotine dependence	0.000235	0.00137	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—WASF2—nicotine dependence	0.000226	0.00132	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—WASF1—nicotine dependence	0.000217	0.00127	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—OPRM1—nicotine dependence	0.000195	0.00114	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—WASF2—nicotine dependence	0.000191	0.00112	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000187	0.00109	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CYP2A7—nicotine dependence	0.000184	0.00107	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—WASF1—nicotine dependence	0.000183	0.00107	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CYP2A7—nicotine dependence	0.000178	0.00104	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—OPRM1—nicotine dependence	0.000165	0.000963	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CYP2A7—nicotine dependence	0.000162	0.000944	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—DRD2—nicotine dependence	0.000141	0.000824	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—DRD2—nicotine dependence	0.000119	0.000697	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CYP2A7—nicotine dependence	0.000119	0.000692	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP2A7—nicotine dependence	8.75e-05	0.000511	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP2A7—nicotine dependence	8.24e-05	0.000481	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP2A7—nicotine dependence	5.39e-05	0.000315	CbGpPWpGaD
